# OnCo record paper-heymach-aegean-perioperative-durvalumab-nejm-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: .
@prefix onco: .
@prefix xsd: .
a schema:ScholarlyArticle ;
onco:kind "paper" ;
schema:identifier "paper-heymach-aegean-perioperative-durvalumab-nejm-2023" ;
schema:name "Perioperative durvalumab for resectable non-small-cell lung cancer"@en ;
schema:description "Giving immunotherapy both before and after lung cancer surgery cut the risk of recurrence by about a third, and left 17.2 percent of tumours with no viable cancer at all in the specimen."@en ;
schema:url ;
schema:dateModified "2026-09-25"^^xsd:date ;
schema:citation , , , ;
onco:tag "lung-evidence" ;
schema:sameAs ;
schema:datePublished "2023"^^xsd:gYear ;
schema:author "Heymach JV, Harpole D, Mitsudomi T, et al." ;
onco:related , , ;
onco:cancers , , ;
onco:sections , ;
onco:technologies ;
onco:targets ;
onco:drugs , , ;
onco:companies ;
onco:pathways ;
onco:terms , ;
onco:people , ;
onco:bottlenecks , , ;
onco:journals , .